TAK-700 in Castration Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bertrand Tombal
Cliniques Universitaires de St Luc, Brussels, Belgium
Study Chair - Cora Sternberg
San Camillo Forlanini Hospitals, Rome, Italy
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Az Groeninge Kortrijk - Campus Vercruysselaan
Kortrijck, Belgium
- Chu Dinant Godinne - Ucl Namur
Yvoir, Belgium
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2014
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2017
- Last update posted
- 10 Jun 2016
- Registered enrollment
- 0
- Registry id
- NCT01658527
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.